Ipamorelin vs Tesamorelin
A uniquely selective growth hormone booster that tells your pituitary to release more GH without messing with your cortisol or other hormones—making it the 'clean' choice among growth hormone peptides.
The only FDA-approved peptide specifically designed to melt away stubborn belly fat by telling your brain to release more growth hormone naturally—working with your body's own systems rather than replacing them [6].
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Ipamorelin
200–200 mcg
Tesamorelin
2–2 mg
Frequency
Ipamorelin
Multiple times daily
Tesamorelin
Once daily
Administration
Ipamorelin
Subcutaneous injection
Tesamorelin
Subcutaneous injection
Cycle length
Ipamorelin
8-12 weeks
Tesamorelin
12+ weeks
Onset speed
Ipamorelin
Moderate (1-2 weeks)
Tesamorelin
Moderate (1-2 weeks)
Evidence level
Ipamorelin
Moderate human trials (Phase 1-2)
Tesamorelin
Strong human trials (Phase 3 or FDA approved)
Benefit ratings
GH Selectivity
Recovery Support
Safety Profile
Visceral Fat Reduction
Metabolic Health
Natural GH Boost
Compound specifications
Ipamorelin
Molecular formula
C38H49N9O5
Molecular weight
711.85 g/mol
Half-life
2 hours
Bioavailability
High when injected subcutaneously
CAS number
170851-70-4
Tesamorelin
Molecular formula
C221H366N72O67S
Molecular weight
5135.86 g/mol
Half-life
26-38 minutes
Bioavailability
~100% (subcutaneous injection)
CAS number
218949-48-5
Dosing compared
Ipamorelin
Subcutaneous
100 mcg per injection
2-3 times daily · 4-8 weeks
Conservative entry dose; Ipamorelin is a selective GH secretagogue with a ~2 hour half-life, so doses are split through the day [1][2]. Used in research and practice to assess tolerance before titrating up.
200 mcg per injection
2-3 times daily · 8-12 weeks
Most commonly cited research/practice dose; gives a meaningful pulsatile GH release without raising cortisol or prolactin at standard doses [1][2].
300 mcg per injection
3 times daily · 8-12 weeks
Upper end of the commonly used range; total daily exposure split across three injections. Used in practice by experienced users [1].
Tesamorelin
Subcutaneous
2 mg (1.4 mg with Egrifta SV/WR F8 formulation)
Once daily · 26 weeks, continued long-term for sustained effect
FDA-approved dose for HIV-associated lipodystrophy; full dose from day one with no titration [6]. Pivotal phase 3 trials used 2 mg daily [1].
Best suited for
Ipamorelin
Clean GH Boost Seekers
If you want the benefits of increased growth hormone without spiking cortisol or other stress hormones, Ipamorelin is uniquely selective. Unlike GHRP-2 or GHRP-6, it won't raise your cortisol levels even at doses 200 times higher than needed for GH release.
Recovery-Focused Athletes
Ipamorelin shines for athletes who want better recovery between training sessions. The GH boost helps repair muscle tissue faster, and since it doesn't mess with other hormones, you can use it consistently without the rollercoaster effects.
Anti-Aging Enthusiasts
Growth hormone naturally declines as we age, contributing to muscle loss, fat gain, and reduced vitality. Ipamorelin offers a gentle way to restore more youthful GH levels without the risks of actual HGH therapy.
Those Recovering from Steroid Use
Research shows Ipamorelin can help counteract the muscle and bone-weakening effects of glucocorticoid medications. If you've been on steroids for medical reasons, this peptide may help you rebuild what you've lost.
Tesamorelin
People with Stubborn Visceral Fat
If you carry your weight around your midsection—the deep belly fat that wraps around your organs—tesamorelin is specifically designed for you. Unlike weight loss drugs, it targets visceral fat while preserving the normal subcutaneous fat that's healthy to have [5].
HIV Patients with Lipodystrophy
Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy—the abnormal fat accumulation in the belly that antiretroviral medications can cause [6]. It's the only treatment proven to help this condition, reducing both the physical and psychological burden [1][5].
Those Concerned About Metabolic Health
Visceral fat isn't just cosmetic—it's metabolically dangerous, linked to heart disease, diabetes, and inflammation [10][12]. By reducing visceral fat, tesamorelin also improves triglycerides, cholesterol ratios, and may help protect your liver from fatty liver disease [1][2][4].
Adults Wanting Natural GH Stimulation
Unlike synthetic growth hormone injections, tesamorelin works WITH your body's natural systems. It tells your pituitary to release more of YOUR OWN growth hormone, maintaining normal feedback loops and reducing the risks associated with supraphysiological GH levels [10].
Side effects
Ipamorelin
Common
- Mild headache
- Injection site reactions
- Water retention
- Increased appetite
Uncommon
- Tingling in hands or feet
- Joint stiffness
Serious
- Allergic reaction
Tesamorelin
Common
- Injection site reactions
- Joint pain (arthralgia)
- Muscle pain (myalgia)
- Peripheral edema
Uncommon
- Carpal tunnel symptoms
- Elevated blood glucose
Serious
- Severe allergic reaction
- Worsening diabetes
Safety & evidence
Ipamorelin
Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Ipamorelin's main selling point is that it raises growth hormone without raising cortisol or ACTH — two stress hormones that similar peptides do raise. That was shown in pigs, and it held even at doses more than 200 times higher than the amount needed to raise growth hormone [1]. It has not been checked in people. The two published human studies measured ipamorelin and growth hormone only; neither one assayed cortisol, ACTH or prolactin [2][3]. Most of what we know about safety in people comes from a single trial in patients recovering from bowel surgery. 114 people took part: 56 got ipamorelin through an IV for up to seven days, and 58 got a placebo. Most side effects were mild to moderate, and were the kind you would expect after surgery [3]. Serious problems happened at about the same rate in both groups — roughly 1 in 6 either way (17.9% on ipamorelin, 15.5% on placebo). But three things were more common on ipamorelin: low potassium in about 1 in 8 people versus about 1 in 30 on placebo (12.5% vs 3.4%), trouble sleeping in about 1 in 9 versus about 1 in 19 (10.7% vs 5.2%), and high blood sugar at discharge in about 1 in 7 versus about 1 in 12 (14.3% vs 8.6%) [6]. Two people taking ipamorelin died. Both had colon cancer surgery, and in both cases the surgical join in the bowel leaked afterward. Nobody on the placebo died. The FDA says it is unclear whether those deaths had anything to do with ipamorelin — but it pointed to them, along with the potassium and blood sugar differences, when it recommended in October 2024 against letting pharmacies compound ipamorelin [6].
Contraindications
- Active cancer or history of cancer
- Pregnancy or breastfeeding
- Pituitary disorders or tumors
- Known allergy to peptide components
- Children and adolescents (growth plates still open)
Tesamorelin
Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for other use
Safety overview
Tesamorelin has a strong safety profile backed by FDA approval and multiple large Phase 3 clinical trials involving over 800 patients [1][6]. The most common issues are injection site reactions and the typical side effects of elevated growth hormone (joint pain, fluid retention) [6]. Glucose metabolism should be monitored as some patients experience increased blood sugar [6]. Long-term cardiovascular safety data is still being collected, which is why the FDA recommends reassessing treatment if visceral fat doesn't reduce [6].
Contraindications
- Active malignancy [6] or history of cancer (pituitary tumors especially)
- Known hypersensitivity to tesamorelin or mannitol [6]
- Pregnancy [6]
- Disruption of the hypothalamic-pituitary axis from conditions like hypophysectomy or pituitary tumor surgery [6]
Which is right for you?
Choose Ipamorelin if...
- Muscle recovery and growth
- Anti-aging and vitality
- Body composition improvement
- Sleep quality enhancement
Choose Tesamorelin if...
- Reducing visceral abdominal fat
- Improving metabolic health markers
- Supporting natural growth hormone production
- Addressing HIV-associated lipodystrophy